REFERENCES
Eaden JA, Abrams KR, Mayberry JF: The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 48:526-535, 2001
Hogezand RA, Eichhorn A, Choudry A, Veenendaal A, Lamers CB: Malignancies in inflammatory bowel disease: fact or fiction? Scand J Gastroenterol Suppl 236:48-53, 2002
Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A: Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 42:711-714, 1998
Palli D, Trallori G, Saieva C, Tarantino O, Edili E, D'Albasio G, Pacini F, Masala G: General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: The Florence Study. Gut 42:175-179, 1998
Mayer R, Wong WD, Rothenberger DA, Goldberg SM, Madoff RD: Colorectal cancer in inflammatory bowel disease: A continuing problem. Dis Colon Rectum 42:343-347, 1999
Solomon MJ, Schnitzler M: Cancer and inflammatory bowel disease: Bias, epidemiology, surveillance, and treatment.World J Surg 22:352-358, 1998
Karlen P, Lofberg R, Brostrom O, Leijonmarck CE, Hellers G, Persson PG: Increased risk of cancer in ulcerative colitis: A population-based cohort study. Am J Gastroenterol 94:1047-1052, 1999
Delco F, Sonnenberg A: The unsolved problem of surveillance for colorectal cancer in ulcerative colitis. Can J Gastroenterol 13:655-660, 1999
Fracasso P, Assisi D, Stigliano V, Casale V: Colorectal cancer complicating ulcerative colitis: An institutional series. J Exp Clin Cancer Res 18:29-32, 1999
Geboes K: Ulcerative colitis and malignancy. Acta Gastroenterol Belg 63:279-283, 2000
Tan CW, Wilson GE, Howat JM, Shereeve DR: Rectal lymphoma in ulcerative colitis treated with azathioprine. Eur J Gastroenterol Hepatol 13:989-992, 2001
Aithal GP, Mansfield JC: Review article: The risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment. Aliment Pharmacol Ther 15:1101-1108, 2001
Garlicki M, Wierzbicki K, Przybylowski P, Drop D, Biernat M, Rudzinski P, Olszewska B, Dziatkowiak A: The incidence of malignancy in heart transplant recipients. Ann Transplant 3:41-47, 1998
Gunji Y, Sakamoto K, Kamura K, Yamada K, Kashiwabara H, Shimada H, Hori S, Suzuki T, Ochiai T: Long-term outcomes of immunosuppressed renal transplant recipients with malignancies. Surg Today 31:492-496, 2001
Yoshimura T, Tamai Y, Takami H, Kariya K, Nakahata R, Tsushima K, Munakata A, Kawamura S: Rapidly progressive irradiated cervical cancer that metastasized to the liver during therapy for idiopathic thrombocytopenic purpura. Rinsho Ketsueki 40:150-152, 1999
Fletcher L, Maddocks JL: Assay of thioinosinic acid, an active metabolite of azathioprine, in human lymphocytes. Br J Clin Pharmacol 10:287-292, 1980
Nielsen OH, Vainer B, Rask-Madsen J: Review article: The treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine. Aliment Pharmacol Ther 15:1699-1708, 2001
Connell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE: Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 343:1249-1252, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sasaki, JI., Kawamura, Y.J., Konishi, F. et al. LETTER: Colitic Cancer Developed After Introduction of Azathioprine. Dig Dis Sci 49, 1727–1729 (2004). https://doi.org/10.1023/B:DDAS.0000043393.67919.fe
Issue Date:
DOI: https://doi.org/10.1023/B:DDAS.0000043393.67919.fe